drugset / Trial / NCT02399592
Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to to investigate the effect of tocotrienol as a nutritional supplement in combination with bevacizumab in patients with advanced ovarian cancer.
Timeline
- Start
- 2015-03
- Primary completion
- 2019-07
- Completion
- 2019-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tocotrienol | Small molecule | 300 mg | — |
| Background | Bevacizumab | Monoclonal antibody | 10 mg/kg | — |